Cite Filings / XFOR / 0001072613-23-000346

Feed Companies Filings Check

Sign in

SC 13D/A

Beneficial Ownership Report

X4 Pharmaceuticals, Inc Filed 2023-05-26 Acc 0001072613-23-000346

Documents 1

SC 13D/A Beneficial Ownership Report , growthequity-x4pharma_18725.htm

Around this filing

2023-06-01 8-K Regulation FD disclosure
2023-06-01 D Notice of Sales of Unregistered Securities
2023-05-31 144 Sale of Securities
2023-05-31 4 President and CEO sold 6,292 shares at $1.95 ($12,269)
2023-05-26 SC 13D/A Beneficial Ownership Report
2022-12-20 SC 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading growthequity-x4pharma_18725.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…